Cargando...
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure
The coronavirus disease (COVID-19) pandemic is a global health priority. Given that cardiovascular diseases (CVD) are the leading cause of morbidity around the world and that several trials have reported severe cardiovascular damage in patients infected with SARS-CoV-2, a substantial number of COVID...
Gardado en:
| Publicado en: | Heart Fail Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7447089/ https://ncbi.nlm.nih.gov/pubmed/32844337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10741-020-10016-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|